Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Imaging in Inflammatory Bowel Disease.
Kumar R, Melmed GY, Gu P. Kumar R, et al. Among authors: melmed gy. Rheum Dis Clin North Am. 2024 Nov;50(4):721-733. doi: 10.1016/j.rdc.2024.07.009. Epub 2024 Aug 26. Rheum Dis Clin North Am. 2024. PMID: 39415376 Review.
Artificial Intelligence- and Physician-Interpreted Stool Image Characteristics Correlate With C-Reactive Protein Among Inpatients With Acute Severe Ulcerative Colitis: A Pilot Study.
Rotondo-Trivette S, Castelan VC, Mathur K, Yasmeh P, Kraus A, Lynch A, McGovern DPB, Melmed GY. Rotondo-Trivette S, et al. Among authors: melmed gy. Crohns Colitis 360. 2024 Aug 26;6(3):otae043. doi: 10.1093/crocol/otae043. eCollection 2024 Jul. Crohns Colitis 360. 2024. PMID: 39206451 Free PMC article.
Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect Comparisons.
Reinisch W, Melmed GY, Nakase H, Seidelin J, Ma C, Xuan S, Tran J, Remple V, Wegrzyn L, Levy G, Sanchez Gonzalez Y, Panaccione R. Reinisch W, et al. Among authors: melmed gy. Adv Ther. 2024 Oct;41(10):3832-3849. doi: 10.1007/s12325-024-02912-y. Epub 2024 Aug 10. Adv Ther. 2024. PMID: 39126596 Free PMC article.
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials.
Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, Peyrin-Biroulet L, D'Haens G, Hisamatsu T, Siegmund B, Wu K, Boland BS, Melmed GY, Armuzzi A, Levine P, Kalabic J, Chen S, Cheng L, Shu L, Duan WR, Pivorunas V, Sanchez Gonzalez Y, D'Cunha R, Neimark E, Wallace K, Atreya R, Ferrante M, Loftus EV Jr; INSPIRE and COMMAND Study Group. Louis E, et al. Among authors: melmed gy. JAMA. 2024 Sep 17;332(11):881-897. doi: 10.1001/jama.2024.12414. JAMA. 2024. PMID: 39037800 Clinical Trial.
When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel Disease.
Systrom HK, Rai V, Singh S, Baidoo L, Cheifetz AS, Devlin SM, Gecse KB, Irving PM, Kaplan GG, Kozuch PL, Ullman T, Sparrow MP, Melmed GY, Siegel CA. Systrom HK, et al. Among authors: melmed gy. Am J Gastroenterol. 2024 Jul 15. doi: 10.14309/ajg.0000000000002964. Online ahead of print. Am J Gastroenterol. 2024. PMID: 39008539
Predictive Factors of Inactive Patient Participation in an Inflammatory Bowel Disease Learning Health System: A Longitudinal Cohort Study.
Dang N, Kumar S, Kwon M, Cradeur M, Zeven K, Khunte M, Marino D, Tse CS, van Deen WK, Lee A, Kamp K, Oberai R, Melmed GY, Siegel CA, Weaver SA, Shah SA. Dang N, et al. Among authors: melmed gy. Inflamm Bowel Dis. 2024 May 22:izae099. doi: 10.1093/ibd/izae099. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 38775837
202 results